iSpecimen shares surge 15.18% after-hours as stockholder approvals boost financial flexibility and Nasdaq compliance.

iSpecimen surged 15.18% in after-hours trading following the announcement that its stockholder meeting approved a reverse stock split, an increase in authorized shares, and amendments to private financing and convertible securities terms. These measures aim to enhance financial flexibility and ensure compliance with Nasdaq regulations, signaling improved corporate governance and capital structure optimization. The approvals address key regulatory hurdles, potentially boosting investor confidence and unlocking future fundraising opportunities. While the stock faces weak technical indicators and a Hold rating, the immediate post-meeting rally reflects market optimism over the structural changes.